G ranulysin, a cytolytic molecule expressed by human CTL and NK cells, is colocalized in granules with perforin and granzymes and is active against tumors and a variety of microbes, including Mycobacterium tuberculosis (1, 2) . Using the human T cell tumor Jurkat, we previously showed that granulysin binds to the cell surface based upon charge and causes increased intracellular Ca 2ϩ ([Ca 2ϩ ] i ) 4 (3) . In granulysin-treated cells, mitochondria are damaged, with a loss of electrostatic potential and release of cytochrome c (3) and apoptosis-inducing factor (AIF) (4) . Although cytochrome c is released, caspase 9 is not activated; other caspases, however, are involved in granulysin-mediated cell death (3) . These studies indicate that the cell membrane and mitochondria are important targets of granulysin. Outstanding issues include identification of the mediators between the cell surface and mitochondria, the mechanism of mitochondrial damage, and downstream events giving rise to DNA degradation.
We show here that an increase in [Ca 2ϩ ] i and a decrease in [K ϩ ] i are required for granulysin-mediated apoptosis. In granulysin-treated cells, both cytosolic and intramitochondrial calcium levels rise, followed by a decrease in intracellular potassium ([K ϩ ] i ) levels. Granulysin-mediated cell death is prevented by both calcium and potassium channel blockers. Granulysin gains entry into the cytoplasm and directly damages mitochondria in the presence of calcium. Inhibitors of electron transport or an increase in cellular glutathione protect Jurkat cells from granulysin-mediated death. Taken together, these findings indicate that mitochondria are the major targets of granulysin and that several different pathways contribute to mitochondrial damage and subsequent cell death.
Materials and Methods

Reagents
Reagents used include the channel blockers, econazole (Sigma-Aldrich, St. Louis, MO); tetraethylammonium chloride, apamin, charybdotoxin, MTT, and thapsigargin (Calbiochem, San Diego, CA); propidium iodide (PI), Fura-2/AM, K ϩ -binding benzofuran isophtalate (PBFI), C2938-AM (6-carboxy-2Ј,7Ј-dichlorodihydrofluorescein diacetate, di(acetoxymethyl ester), and Rhod-2/AM (Molecular Probes, Eugene, OR); mitochondrial electron transport inhibitors, antimycin A, rotenone, carbonyl cyanide m-chlorophenylhydrazone (CCCP), and potassium cyanide (KCN; SigmaAldrich); HRP-conjugated secondary Abs and ECL reagents (Amersham Pharmacia Biotech, Piscataway, NJ); anti-cytochrome c Ab (BD PharMingen, San Diego, CA); anti-AIF Ab (Santa Cruz Biotechnology, Santa Cruz, CA); anti-actin Ab (Oncogene, San Diego, CA); and FITC-dUTP and TdT (BD PharMingen).
Cells
Jurkat cells were obtained from American Type Culture Collection (Manassas, VA) and were maintained in RPMI 1640 supplemented with 10% FBS (HyClone, Logan, UT), 200 U/ml penicillin, 200 g/ml streptomycin, and 2 mM L-glutamine.
Granulysin and granulysin-derived peptides
Recombinant granulysin (9 kDa) was expressed and purified as previously described (2) . Granulysin peptides G8 and G9 were synthesized as previously described (5). G8 and G9 include residues 23-51 of granulysin and are identical, except that cysteine was replaced by serine at positions 34 and 45 in G9 (5).
Cytotoxicity assays
Jurkat cells were seeded in 96-well plates at a density of 8 ϫ 10 5 /ml (100 l/well) in RPMI 1640 supplemented with 0.1% FCS. Cells were cultured for 3 h after the addition of granulysin. Cell death was measured by PI uptake (6) , DNA fragmentation (3), or MTT assay (7).
[Ca 2ϩ ] i and [K ϩ ] i measurements
The cells were then washed twice with PBS and incubated for an additional 30 min for complete de-esterification. [Ca 2ϩ ] i and [K ϩ ] i were monitored using an Attofluor digital fluorescence microscope (Atto Instruments, Rockville, MD). Briefly, a cell suspension was loaded into chambers, and after 50 s the test agent was added. The Ca 2ϩ -or K ϩ -dependent fluorescence signal was obtained using dual excitation at 334 and 380 nm and ratioing fluorescence intensities detected at 510 nm. In some experiments high K ϩ modified RPMI 1640 medium containing 140 mM KCl and 5 mM NaCl was used as previously described (8) .
DNA fragmentation
Cells treated with granulysin or control were washed in saline, fixed with 1% paraformaldehyde for 15 min at 4°C, and suspended in 70% ethanol for 30 min at 4°C. The cells were then washed in saline and mixed with 50 l of a mixture containing 2 M potassium cacodylate, 25 mM Tris-HCl, 2.5 mM cobalt chloride, and FITC-dUTP in the presence of 100 g/ml of TdT. After two washes with saline, the cells were resuspended in 500 l of PBS containing 10 g/ml PI plus 10 g/ml RNase, incubated for 30 min at room temperature in the dark, and analyzed by flow cytometry using a FACScan (BD Biosciences, Mountain View, CA). Nonclumped cells were gated based on a display with DNA area and DNA width, and a second gated dual parameter display with FITC-dUTP and DNA area was generated. Cells without DNA fragmentation were gated based on FITC-dUTP fluorescence in control cells.
Electron microscopy
Jurkat cells (5 ϫ 10 5 /ml) were suspended in RPMI 1640 without FCS and incubated with 50 M granulysin for 20 min at 37 o C. The cells were washed twice in 0.1 M phosphate buffer and resuspended in 0.2 ml of fixation buffer (2% formaldehyde and 0.5% glutaraldehyde in 0.1 M phosphate buffer) on ice for 15 min. The samples were centrifuged, the supernatant was removed, 0.2 ml of fixation buffer was added, and the cells were incubated on ice for another 20 min. Cells were washed twice in cold 0.1 M phosphate buffer and processed for electron microscopy. Sections were stained with rabbit anti-human granulysin Ab (9), followed by Immunogold-conjugated goat anti-rabbit IgG (1/10).
Subcellular fractionation and Western blot
Mitochondrial and cytosolic (S100) fractions were prepared as previously described (3) by resuspending Jurkat cells in 0.8 ml of ice-cold buffer A (250 mM sucrose, 20 mM HEPES, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 17 g/ml PMSF, 8 g/ml aprotinin, and 2 g/ml leupeptin (pH 7.4)). Cell membranes were disrupted by repeatedly forcing cells through a 30-gauge needle. Unlysed cells and nuclei were pelleted at 750 ϫ g for 10 min, and the supernatant was centrifuged at 10,000 ϫ g for 25 min. The pellet (representing the mitochondria-enriched fraction) was resuspended in lysis buffer; the supernatant was subjected to further centrifugation at 100,000 ϫ g for 1 h. The supernatant from the final centrifugation represents the S100 fraction. Mitochondrial (5 g protein/lane) and S100 (10 g protein/lane) fractions were subjected to Western blot analysis as previously described (3) . Blots were incubated with mAb specific for cytochrome c, AIF, or actin and were diluted in Trisbuffered saline supplemented with 0.2% Tween 20. Primary Abs were detected by peroxidase-labeled secondary Ab and were developed using ECL. In experiments to determine the effects of granulysin on isolated mitochondria, mitochondria were resuspended in regenerating buffer (100 mM TrisHCl (pH 7.4), 10 mM sodium citrate, 2 mM NAD ϩ , and 1 mM MgCl 2 ) as indicated.
Mitochondrial calcium
Mitochondrial calcium was measured using Rhod-2/AM. Jurkat cells were cultured in a poly-L-lysine-coated chamber and were incubated with 1 M Rhod-2/AM (10) for 30 min. Cells were washed with PBS and then further incubated overnight in RPMI 1640 supplemented with 10% FCS to eliminate extracellular dye. Immediately before use, cells were washed again and resuspended in RPMI 1640 supplemented with 0.1% FCS. Rhod-2 fluorescence was monitored using a confocal microscope.
Reactive oxygen species (ROS)
Jurkat cells were incubated with granulysin or medium for 1 h. The cells were then washed and incubated with 0.5 M C2938 for 1 h, washed, and resuspended in PBS. Cells were incubated with PI (3 g/ml) for an additional 30 min and washed, and two-color fluorescence was analyzed by FACScan (BD Biosciences, San Jose, CA).
Treatment with 2-oxo-4-thiazolidine carboxylic acid (OTC) or buthionine sulfoximine (BSO)
Jurkat cells were incubated with 10 mM OTC (a cysteine prodrug that is metabolized to cysteine intracellularly, and thus can contribute to glutathione synthesis) (11, 12) or 100 M BSO (a specific inhibitor of glutathione synthesis) (13) for 24 h. After washing, apoptosis and glutathione content (14) were determined.
Results
An increase in [Ca 2ϩ ] i is required for both granulysin-and granulysin peptide-induced apoptosis
We previously reported that granulysin induces an increase in [Ca 2ϩ ] i in Jurkat cells (3) . In the present study we asked whether this increase in [Ca 2ϩ ] i was required for apoptosis induced by granulysin or its derivative peptides, G8 and G9. Peptide G8 corresponds to residues 23-51 and lyses Jurkat cells. Peptide G9 is identical with G8, except that the cysteine residues at positions 34 and 45 were replaced with serine; G9 does not lyse Jurkat cells (5) . Granulysin and peptide G8 cause an increase in [Ca 2ϩ ] i within 200 s after treatment of Jurkat cells with 50 M granulysin or 25 M G8 (Fig. 1, A and D) . Peptide G9 does not increase [Ca 2ϩ ] i (Fig. 1G) . In lymphocytes, ligation of the Ag receptor leads to a release of Ca 2ϩ from intracellular stores, including the endoplasmic reticulum and mitochondria, which, in turn, causes the activation of Ca 2ϩ channels in the plasma membrane. The latter channels are therefore referred to as store-operated Ca 2ϩ channels (SOC) (15) . To determine whether SOC were involved in the granulysin-induced rise in [Ca 2ϩ ] i , Jurkat cells were then preincubated with the SOC blockers nickel and econazole before addition of G8, G9, or granulysin. Both nickel and econazole prevented the granulysin or G8-induced increase in [Ca 2ϩ ] i (Fig. 1, B , C, E, and F) and inhibited granulysin-or G8-induced apoptosis (Table  I) (Fig. 1, H and I) (Fig. 2M) . The granulysin-mediated decrease in [K ϩ ] i was prevented by the inclusion of potassium channel blockers (Fig. 2, B-D and H-J). Granulysin decreased [K ϩ ] i from ϳ120 to Ͻ60 mM within 15 min (Fig. 2N) . Increasing [Ca 2ϩ ] i by treatment with either ionomycin (Fig. 2F) or thapsigargin (Fig. 2L) 
Granulysin enters cells and increases mitochondrial calcium
To determine whether granulysin remained associated with the plasma membrane, Jurkat cells were treated with 50 M granulysin for 20 min, washed, fixed, and processed for electron microscopy. Immunogold staining throughout the cell, including mitochondria, endoplasmic reticulum, Golgi, nucleus, and cytosol, was evident by 20 min (Fig. 3) , indicating that granulysin rapidly enters target cells and does not localize to a particular organelle. Cells incubated with granulysin for 1-2 min before processing for electron microscopy showed no staining (not shown . Cytoplasmic K ϩ was determined by calibration of PBFI using the potassium ionophore valinomycin (N) as previously described (46) . All experiments were performed a minimum of three times. [Ca 2ϩ ] m did not change in cells treated with ionomycin and thapsigargin. Thus, granulysin, but not ionomycin or thapsigargin, induced a large increase in [Ca 2ϩ ] m in Jurkat cells.
Granulysin damages isolated mitochondria in the presence of calcium
We previously reported that recombinant granulysin did not damage isolated mitochondria, suggesting that other molecules acted as intermediaries between the plasma membrane and mitochondria (3). However, these experiments were performed in medium that lacked calcium. Our results, indicating a major role of calcium in granulysin-mediated apoptosis, prompted us to re-examine this finding in medium supplemented with calcium (Fig. 5 ). In the presence of calcium and regenerating buffer, isolated mitochondria were damaged by recombinant granulysin, releasing both AIF and cytochrome c.
Granulysin induces ROS production
Because granulysin damages mitochondria directly, we investigated ROS generation in granulysin-treated Jurkat cells. ROS increased in granulysin-treated Jurkat cells (Fig. 6A) , and this increase was inhibited when cells were incubated in medium containing EGTA, suggesting that the granulysin-induced ROS increase is calcium dependent. Granulysin-induced ROS is also inhibited by preincubation of Jurkat cells with rotenone (Fig. 6B ). This observation suggested that mitochondrial electron transport was involved. Therefore, we tested the effects of granulysin on Jurkat cells preincubated with electron transport complex inhibitors (Fig. 7,  A-F) . Rotenone, antimycin, and KCN all inhibited granulysin-induced cell death. Next, the effect of electron transport inhibitors on granulysin-induced mitochondrial damage was studied. Rotenone inhibited the release of cytochrome c and AIF from mitochondria by granulysin (Fig. 7, G and H) .
Rotenone and CCCP had no significant effect on the granulysininduced increase in [Ca 2ϩ ] i (Fig. 8, A-C) . In contrast, both rotenone and CCCP inhibited the granulysin-induced [Ca 2ϩ ] m increase (Fig. 8D ). These data indicate that electron transport is involved in calcium uptake into mitochondria and that inhibition of this uptake blocks granulysin-mediated cell death.
Glutathione affects granulysin-mediated cell death
Taken together, these findings implicate the redox state in granulysin-mediated cell death and suggest that changing intracellular glutathione levels may affect granulysin-mediated apoptosis. To test this hypothesis, Jurkat cells were preincubated with OTC or BSO. The glutathione level in cells treated with OTC, which is transported into cells and metabolized into cysteine by 5Ј-oxoprolinase (18) , increased 200%, while the glutathione level in cells treated with BSO, an irreversible inhibitor of ␥-glutamylcysteine synthetase (18) , decreased by Ͼ90% (data not shown). Granulysin-induced apoptosis was significantly inhibited in OTC-treated Jurkat cells (Fig. 9A ), while only a minimal effect was observed in BSO-treated cells (Fig. 9B) . Thus, the redox state affects susceptibility to granulysin-mediated cell death.
Discussion
In this study we demonstrate that one of the earliest events following the interaction of granulysin with cells is a store-operated Ca 2ϩ channel-dependent release of Ca 2ϩ from the endoplasmic reticulum. Remarkably, this Ca 2ϩ release occurs before measurable breakdown of the plasma membrane and appears to be an almost immediate event (3). The increase in [Ca 2ϩ ] i leads to a decrease in [K ϩ ] i , presumably by opening a calcium-dependent potassium channel. Cells treated with granulysin exhibit an increase in [Ca 2ϩ ] m that is blocked by inhibitors of electron transport. Granulysin does not remain associated with the plasma membrane; rather, it enters the cell, where it may inflict further injury. Recombinant granulysin damages isolated mitochondria in the presence of calcium and ATP-regenerating buffer. Once damaged, mitochondria release AIF and cytochrome c and generate ROS, further potentiating apoptosis. Taken together, these data add to our understanding of the pathways from the cell surface to the mitochondria and implicate calcium, potassium, redox state, ROS, and oxidative metabolism in granulysin-mediated apoptosis. Ca 2ϩ is a common signal in many different cell death pathways, and there is an intricate relationship among mitochondrial function, ROS production, Ca 2ϩ , and cell death (19) . Depletion of the endoplasmic reticulum Ca 2ϩ pool can lead to apoptosis, while loss of mitochondrial function causes an increase in cytosolic Ca 2ϩ . Overload of [Ca 2ϩ ] i has long been implicated in the final common pathway in cell death (20) . Recently, it has become clear that large increases in [Ca 2ϩ ] i are associated with necrosis, whereas less dramatic increases are associated with apoptosis. Our observation that granulysin induces a 2-to 3-fold increase in [Ca 2ϩ ] i in Jurkat cells that go on to apoptosis is consistent with findings using other apoptosis-inducing agents in other cell types (21) (22) (23) . Ca 2ϩ release from the endoplasmic reticulum and/or capacitative Ca 2ϩ influx through Ca 2ϩ release-activated Ca 2ϩ channels induces apoptosis (24, 25) . Again, our finding that granulysin causes initial release of Ca 2ϩ from intracellular stores/endoplasmic reticulum is consistent with Ca 2ϩ -induced apoptosis. It has been proposed that release of Ca 2ϩ from intracellular stores may trigger apoptosis due to the proximity of mitochondria (26) . Mitochondria take up this Ca 2ϩ , and the increase in mitochondrial Ca 2ϩ may trigger the opening of transition pores and the release of cytochrome c and AIF. We previously reported that granulysin caused a rapid increase in [Ca 2ϩ ] i (3) and the release of AIF from mitochondria (4), consistent with these hypotheses. We show here that granulysin induces a much larger increase in [Ca 2ϩ ] m than either ionomycin or thapsigargin, and the increase in [Ca 2ϩ ] m is abrogated by the electron transport inhibitors CCCP and rotenone. A decrease in [K ϩ ] i has previously been associated with apoptosis (6, 27) . Physiologic levels of [K ϩ ] i play a key role in maintaining caspases in their inactive proforms (28) . Activated caspases, especially caspase 3, orchestrate DNA fragmentation, nuclear condensation, and membrane blebbing as well as damage to mitochondria (29) . We previously demonstrated that caspase 3 is activated in granulysin-treated cells (3) . Activation of caspase 3 may result from the decrease in [K ϩ ] i or from mitochondrial damage and loss of components that form the caspase-activating apoptosome. Loss of K ϩ also results in cell shrinkage that is associated with apoptosis.
Disruption of mitochondrial transmembrane potential (⌬ m ) is thought to be the point of no return in apoptotic signaling (30, 31) . We showed earlier that ⌬ m is decreased in granulysin-treated Jurkat cells (3) . ROS levels are partially inhibited in N-acetyl-AspGlu-Val-Asp-aldehyde-treated Jurkat cells activated by Fas, suggesting that caspase 3 activation, perhaps through damage of mitochondrial membrane integrity, contributes to ROS production and serves as a positive feedback loop at later stages of the apoptotic process. Green and co-workers (29) showed that both the rapid loss of ⌬ m and the generation of ROS are due to the effects of activated caspases on mitochondrial electron transport complexes I and II. Caspase 3 disrupts oxygen consumption induced by complex I and II substrates, but not that induced by electron transfer to complex IV. These findings indicate that after cytochrome c release the activation of caspases feeds back on the permeabilized mitochondria to damage mitochondrial function (loss of ⌬ m ) and generate ROS through effects of caspases on complex I and II in the electron transport chain. Intracellular levels of ROS are controlled by a balance of mitochondrial ROS production and the concentration of reducing equivalents, such as glutathione. Increased production of ROS was demonstrated in TNF-(32-34) and Fas-mediated (35-37) cell death. We report here that ROS are increased in granulysin-treated cells.
Mitochondrial ⌬ m is generated by the electron transport system that consumes O 2 and pumps protons across the mitochondrial inner membrane to produce ATP. Rotenone, antimycin A, and KCN hamper this process by disturbing complex I, III, or IV of the electron transport chain, respectively. We found that these inhibitors reduced granulysin-induced apoptosis. Rotenone prevented the release of AIF and cytochrome c from granulysin-treated cells. The inhibitor CCCP is a protonophore that disrupts the mitochondrial proton gradient. Collapsing this gradient abrogates mitochondrial membrane potential and thereby disrupts the gradient driving Ca 2ϩ into mitochondria (38, 39) . This explains in part why rotenone and CCCP inhibit the granulysin-mediated increase in [Ca 2ϩ ] m . The permeability of the mitochondrial membrane is regulated by an oxidation-reduction equilibrium of ROS, pyridine nucleotides, and glutathione levels. Glutathione is the most important intracellular reducing compound in cells, making up Ͼ90% of the intracellular nonprotein thiols that are sequestered in subcellular components. It is the major determinant of the intracellular redox potential (40) and is an important determinant of cellular apoptotic potential (41) . We show here that increasing the intracellular glutathione level in OTC-treated cells protected from granulysin induced apoptosis, while decreasing the intracellular glutathione level in cells treated with BSO had minimal effects. We expected that decreasing intracellular glutathione by Ͼ90% would render cells more susceptible to the effects of granulysin. However, this was not the case, suggesting that the residual glutathione was sufficient to protect cells from some of the effects of granulysin. We were unable to reduce the intracellular glutathione levels further, as treatment of cells with Ͼ100 M BSO resulted in increased cell death in the absence of added granulysin.
Several lines of evidence point to mitochondrial calcium uptake as a triggering point for ROS generation (42) (43) (44) . Three dehydrogenases of the Krebs cycle (pyruvate, isocitrate, and oxoglutarate dehydrogenase) are activated by [Ca 2ϩ ] m , which, in turn, leads to increased availability of NADH to the electron transport system. Eventually these electrons are transferred from NADH and FADH 2 to oxygen. This can also result in oxygen free radical generation, since there is a tendency for electrons to transfer to oxygen directly rather than to the next component in the chain. Our observations that 1) rotenone prevents the release of cytochrome c induced by granulysin; 2) rotenone decreases the production of ROS in granulysin-treated cells; and 3) ROS generation occurs after the granulysin-induced [Ca 2ϩ ] m increase are consistent with the increase in [Ca 2ϩ ] m as the initial trigger for granulysin-induced apoptosis.
Mitochondria appear to be the major targets of granulysin-mediated apoptosis of Jurkat tumor T cells. Several different pathways converge on the energy-generating machinery of the cell. Here we identify several mediators of this process, including [Ca 2ϩ ] i , [K ϩ ] i , and granulysin itself. Preliminary results with microarrays of Mycobacteria tuberculosis treated with granulysin show similar pathways of membrane damage, ion fluxes, and interference with the redox state and oxidative metabolism. It is likely that the tumoricidal activity of granulysin is a byproduct of its evolved function as an antimicrobial peptide. Of note, however, it is possible to separate these activities with synthetic peptides (5), offering the opportunity to design antimicrobial therapies with limited toxicity to mammalian cells. On the other hand, granulysin toxicity to tumor cells far exceeds its activity against normal cells, such as macrophages and dendritic cells (1) , suggesting that granulysin may prove a potent antitumor agent as well (45) .
